Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythropoiesis | 18 | 2024 | 35 | 5.650 |
Why?
|
| Erythroid Precursor Cells | 10 | 2024 | 20 | 4.150 |
Why?
|
| Erythropoietin | 10 | 2022 | 35 | 1.680 |
Why?
|
| Cell Cycle | 7 | 2024 | 382 | 1.620 |
Why?
|
| Erythrocytes | 4 | 2021 | 146 | 1.570 |
Why?
|
| Receptors, Erythropoietin | 9 | 2021 | 10 | 1.420 |
Why?
|
| Stress, Physiological | 6 | 2013 | 185 | 1.410 |
Why?
|
| Erythroblasts | 9 | 2021 | 15 | 1.380 |
Why?
|
| S Phase | 6 | 2024 | 74 | 1.380 |
Why?
|
| Signal Transduction | 17 | 2024 | 2903 | 1.170 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2020 | 276 | 1.170 |
Why?
|
| Cell Differentiation | 14 | 2024 | 1304 | 0.970 |
Why?
|
| fas Receptor | 3 | 2011 | 55 | 0.890 |
Why?
|
| Homeostasis | 3 | 2013 | 346 | 0.890 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 3 | 2022 | 6 | 0.850 |
Why?
|
| Flow Cytometry | 7 | 2022 | 645 | 0.850 |
Why?
|
| Stem Cells | 2 | 2022 | 255 | 0.850 |
Why?
|
| Mice | 29 | 2022 | 10294 | 0.780 |
Why?
|
| Cell Size | 1 | 2021 | 40 | 0.760 |
Why?
|
| Receptors, Transferrin | 4 | 2021 | 33 | 0.750 |
Why?
|
| Animals | 37 | 2022 | 19650 | 0.730 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2011 | 318 | 0.690 |
Why?
|
| Antigens, CD | 4 | 2021 | 343 | 0.680 |
Why?
|
| bcl-X Protein | 4 | 2021 | 19 | 0.660 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 718 | 0.650 |
Why?
|
| Embryonic Stem Cells | 1 | 2020 | 151 | 0.650 |
Why?
|
| DNA Replication | 3 | 2017 | 228 | 0.640 |
Why?
|
| Fas Ligand Protein | 3 | 2011 | 39 | 0.630 |
Why?
|
| Trans-Activators | 4 | 2010 | 300 | 0.620 |
Why?
|
| STAT5 Transcription Factor | 5 | 2012 | 14 | 0.600 |
Why?
|
| Fetus | 4 | 2021 | 93 | 0.580 |
Why?
|
| Erythroid Cells | 1 | 2017 | 9 | 0.560 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 178 | 0.550 |
Why?
|
| Hematopoiesis | 5 | 2020 | 120 | 0.520 |
Why?
|
| Cell Survival | 5 | 2021 | 559 | 0.480 |
Why?
|
| Models, Biological | 3 | 2021 | 1143 | 0.470 |
Why?
|
| Liver | 6 | 2021 | 795 | 0.440 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2013 | 5 | 0.420 |
Why?
|
| Polycythemia Vera | 1 | 2013 | 6 | 0.420 |
Why?
|
| beta-Thalassemia | 1 | 2013 | 13 | 0.420 |
Why?
|
| DNA Methylation | 2 | 2011 | 271 | 0.400 |
Why?
|
| Milk Proteins | 3 | 2001 | 44 | 0.380 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 146 | 0.360 |
Why?
|
| Embryo, Mammalian | 3 | 2021 | 156 | 0.360 |
Why?
|
| Mice, Inbred BALB C | 7 | 2018 | 868 | 0.350 |
Why?
|
| Receptors, Prolactin | 3 | 2002 | 6 | 0.350 |
Why?
|
| Receptors, Cytokine | 3 | 1998 | 13 | 0.330 |
Why?
|
| Apoptosis | 6 | 2011 | 1033 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 3231 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2018 | 31 | 0.300 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2020 | 619 | 0.280 |
Why?
|
| Anemia | 3 | 2012 | 119 | 0.280 |
Why?
|
| Macrophages | 1 | 2013 | 1015 | 0.280 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2020 | 103 | 0.260 |
Why?
|
| Membrane Proteins | 1 | 2011 | 850 | 0.250 |
Why?
|
| Aging | 1 | 2011 | 710 | 0.250 |
Why?
|
| DNA-Binding Proteins | 3 | 2001 | 1151 | 0.230 |
Why?
|
| Genome | 2 | 2020 | 257 | 0.220 |
Why?
|
| Transcription, Genetic | 4 | 2017 | 841 | 0.220 |
Why?
|
| Female | 11 | 2021 | 30724 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2001 | 99 | 0.200 |
Why?
|
| Integrin alpha6 | 1 | 2022 | 19 | 0.200 |
Why?
|
| Reticulocytes | 1 | 2021 | 12 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2021 | 29 | 0.190 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 66 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 159 | 0.180 |
Why?
|
| CD4 Antigens | 1 | 2021 | 148 | 0.180 |
Why?
|
| Iron | 1 | 2021 | 136 | 0.180 |
Why?
|
| Cell Division | 3 | 2020 | 443 | 0.180 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 59 | 0.180 |
Why?
|
| Oxygen | 2 | 2014 | 313 | 0.180 |
Why?
|
| Single-Cell Analysis | 2 | 2018 | 91 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 650 | 0.170 |
Why?
|
| Hematologic Diseases | 1 | 2020 | 12 | 0.170 |
Why?
|
| Male | 8 | 2021 | 27747 | 0.170 |
Why?
|
| Endodeoxyribonucleases | 1 | 2019 | 41 | 0.160 |
Why?
|
| Mast Cells | 2 | 2018 | 41 | 0.160 |
Why?
|
| Humans | 13 | 2024 | 59389 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2020 | 2092 | 0.160 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1552 | 0.160 |
Why?
|
| Th1 Cells | 1 | 2019 | 177 | 0.160 |
Why?
|
| Basophils | 1 | 2018 | 14 | 0.150 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2018 | 259 | 0.150 |
Why?
|
| Cell Nucleus | 1 | 2021 | 608 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 220 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 297 | 0.140 |
Why?
|
| Interferon-gamma | 1 | 2019 | 551 | 0.140 |
Why?
|
| Mice, Knockout | 5 | 2016 | 1997 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2010 | 306 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 152 | 0.140 |
Why?
|
| Cytokines | 2 | 1998 | 915 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2016 | 4 | 0.130 |
Why?
|
| Osteoclasts | 1 | 2016 | 47 | 0.130 |
Why?
|
| Bone Resorption | 1 | 2016 | 41 | 0.130 |
Why?
|
| Spleen | 2 | 2011 | 479 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2022 | 3067 | 0.120 |
Why?
|
| Osteoblasts | 1 | 2016 | 195 | 0.120 |
Why?
|
| Transcriptome | 1 | 2018 | 340 | 0.120 |
Why?
|
| Pinocytosis | 1 | 1994 | 4 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 1994 | 35 | 0.110 |
Why?
|
| Fibroblasts | 2 | 2003 | 377 | 0.110 |
Why?
|
| Systems Biology | 1 | 2014 | 29 | 0.110 |
Why?
|
| ras Proteins | 2 | 2003 | 77 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1099 | 0.100 |
Why?
|
| Phagocytosis | 1 | 1994 | 260 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2012 | 8 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 14 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 446 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2012 | 230 | 0.100 |
Why?
|
| Locus Control Region | 1 | 2011 | 5 | 0.100 |
Why?
|
| beta-Globins | 1 | 2011 | 9 | 0.100 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2011 | 19 | 0.100 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 16 | 0.100 |
Why?
|
| Dinucleoside Phosphates | 1 | 2011 | 32 | 0.090 |
Why?
|
| Atmosphere | 1 | 2011 | 2 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 1 | 2011 | 25 | 0.090 |
Why?
|
| Receptors, Fc | 1 | 2011 | 21 | 0.090 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 42 | 0.090 |
Why?
|
| Chromatin | 2 | 2020 | 599 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 365 | 0.090 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2011 | 38 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2053 | 0.090 |
Why?
|
| Hematocrit | 2 | 2001 | 32 | 0.090 |
Why?
|
| CpG Islands | 1 | 2011 | 211 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2011 | 130 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 394 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2012 | 883 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 254 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2011 | 331 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 327 | 0.080 |
Why?
|
| Algorithms | 2 | 2018 | 974 | 0.070 |
Why?
|
| Mitochondria | 1 | 2011 | 343 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2006 | 1466 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 490 | 0.070 |
Why?
|
| Cell Separation | 1 | 2007 | 145 | 0.070 |
Why?
|
| Leukemia | 1 | 2007 | 57 | 0.070 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2006 | 10 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 1206 | 0.060 |
Why?
|
| Adult | 1 | 2021 | 15683 | 0.060 |
Why?
|
| Cell Line | 3 | 2001 | 1983 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 124 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 527 | 0.060 |
Why?
|
| Pregnancy | 1 | 2011 | 2213 | 0.060 |
Why?
|
| Genes, ras | 1 | 2003 | 27 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 36 | 0.050 |
Why?
|
| Genotype | 2 | 2003 | 617 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2001 | 15 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2002 | 78 | 0.050 |
Why?
|
| Fetal Diseases | 1 | 2001 | 21 | 0.050 |
Why?
|
| Vascular Neoplasms | 1 | 2001 | 16 | 0.050 |
Why?
|
| Ligases | 1 | 2001 | 26 | 0.050 |
Why?
|
| Hemangioma | 1 | 2001 | 28 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 70 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 495 | 0.040 |
Why?
|
| Chromosomes, Mammalian | 1 | 2020 | 33 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2020 | 21 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1999 | 7 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1999 | 29 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 194 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 1999 | 54 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2001 | 210 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 1998 | 26 | 0.040 |
Why?
|
| Prolactin | 1 | 1998 | 40 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1998 | 132 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2001 | 276 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 169 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 41 | 0.040 |
Why?
|
| Rabbits | 1 | 1998 | 322 | 0.040 |
Why?
|
| Tyrosine | 1 | 1998 | 92 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 474 | 0.030 |
Why?
|
| Base Sequence | 1 | 1999 | 1302 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 689 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 1553 | 0.030 |
Why?
|
| Bone Density | 1 | 2016 | 129 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 1951 | 0.030 |
Why?
|
| Proteins | 1 | 2001 | 730 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 174 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1994 | 12 | 0.030 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1994 | 8 | 0.030 |
Why?
|
| Zymosan | 1 | 1994 | 25 | 0.030 |
Why?
|
| Sheep | 1 | 1994 | 169 | 0.030 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 9 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 1118 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 114 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 64 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 3615 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 288 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 171 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 526 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 378 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 450 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2005 | 18 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 83 | 0.020 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2005 | 22 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 77 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 128 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 234 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2005 | 173 | 0.010 |
Why?
|
| MyoD Protein | 1 | 2003 | 44 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 188 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 392 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2003 | 193 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 847 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2001 | 6 | 0.010 |
Why?
|
| Polycythemia | 1 | 2001 | 4 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 274 | 0.010 |
Why?
|
| Albumins | 1 | 2001 | 34 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 217 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 161 | 0.010 |
Why?
|
| Biopolymers | 1 | 2001 | 69 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 881 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 391 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 401 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 411 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 1999 | 49 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 69 | 0.010 |
Why?
|
| Alleles | 1 | 2001 | 411 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 486 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 674 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 920 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1998 | 22 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1998 | 25 | 0.010 |
Why?
|
| DNA Repair | 1 | 1999 | 242 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 248 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 303 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 1137 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 2456 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1999 | 808 | 0.010 |
Why?
|
| DNA | 1 | 1998 | 805 | 0.010 |
Why?
|